Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade

This commentary summarizes current knowledge on the clinical presentation, management, and outcomes of the inflammatory arthritis which may occur as an immune‐related adverse evet of immune checkpoint inhibitor therapy. Herein, we propose a new algorithm aimed at assisting oncologists in the diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Naidoo, Jarushka, Cappelli, Laura C., Forde, Patrick M., Marrone, Kristen A., Lipson, Evan J., Hammers, Hans J., Sharfman, William H., Le, Dung T., Baer, Alan N., Shah, Ami A., Albayda, Jemima, Manno, Rebecca L., Haque, Uzma, Gutierrez, Anna Kristina, Bingham, Clifton O., Brahmer, Julie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469592/
https://www.ncbi.nlm.nih.gov/pubmed/28576858
http://dx.doi.org/10.1634/theoncologist.2016-0390
_version_ 1783243606008528896
author Naidoo, Jarushka
Cappelli, Laura C.
Forde, Patrick M.
Marrone, Kristen A.
Lipson, Evan J.
Hammers, Hans J.
Sharfman, William H.
Le, Dung T.
Baer, Alan N.
Shah, Ami A.
Albayda, Jemima
Manno, Rebecca L.
Haque, Uzma
Gutierrez, Anna Kristina
Bingham, Clifton O.
Brahmer, Julie R.
author_facet Naidoo, Jarushka
Cappelli, Laura C.
Forde, Patrick M.
Marrone, Kristen A.
Lipson, Evan J.
Hammers, Hans J.
Sharfman, William H.
Le, Dung T.
Baer, Alan N.
Shah, Ami A.
Albayda, Jemima
Manno, Rebecca L.
Haque, Uzma
Gutierrez, Anna Kristina
Bingham, Clifton O.
Brahmer, Julie R.
author_sort Naidoo, Jarushka
collection PubMed
description This commentary summarizes current knowledge on the clinical presentation, management, and outcomes of the inflammatory arthritis which may occur as an immune‐related adverse evet of immune checkpoint inhibitor therapy. Herein, we propose a new algorithm aimed at assisting oncologists in the diagnosis and management of this immune‐related adverse event.
format Online
Article
Text
id pubmed-5469592
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-54695922017-07-13 Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade Naidoo, Jarushka Cappelli, Laura C. Forde, Patrick M. Marrone, Kristen A. Lipson, Evan J. Hammers, Hans J. Sharfman, William H. Le, Dung T. Baer, Alan N. Shah, Ami A. Albayda, Jemima Manno, Rebecca L. Haque, Uzma Gutierrez, Anna Kristina Bingham, Clifton O. Brahmer, Julie R. Oncologist Commentary This commentary summarizes current knowledge on the clinical presentation, management, and outcomes of the inflammatory arthritis which may occur as an immune‐related adverse evet of immune checkpoint inhibitor therapy. Herein, we propose a new algorithm aimed at assisting oncologists in the diagnosis and management of this immune‐related adverse event. AlphaMed Press 2017-06-02 2017-06 /pmc/articles/PMC5469592/ /pubmed/28576858 http://dx.doi.org/10.1634/theoncologist.2016-0390 Text en © 2017 AlphaMed Press
spellingShingle Commentary
Naidoo, Jarushka
Cappelli, Laura C.
Forde, Patrick M.
Marrone, Kristen A.
Lipson, Evan J.
Hammers, Hans J.
Sharfman, William H.
Le, Dung T.
Baer, Alan N.
Shah, Ami A.
Albayda, Jemima
Manno, Rebecca L.
Haque, Uzma
Gutierrez, Anna Kristina
Bingham, Clifton O.
Brahmer, Julie R.
Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
title Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
title_full Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
title_fullStr Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
title_full_unstemmed Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
title_short Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
title_sort inflammatory arthritis: a newly recognized adverse event of immune checkpoint blockade
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469592/
https://www.ncbi.nlm.nih.gov/pubmed/28576858
http://dx.doi.org/10.1634/theoncologist.2016-0390
work_keys_str_mv AT naidoojarushka inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT cappellilaurac inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT fordepatrickm inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT marronekristena inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT lipsonevanj inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT hammershansj inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT sharfmanwilliamh inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT ledungt inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT baeralann inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT shahamia inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT albaydajemima inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT mannorebeccal inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT haqueuzma inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT gutierrezannakristina inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT binghamcliftono inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade
AT brahmerjulier inflammatoryarthritisanewlyrecognizedadverseeventofimmunecheckpointblockade

Ejemplares similares